Apprentice.io

Check out our latest Industry Insights podcast with Frank Maggiore: BioIndustrial Enzymes - Solving the Plastic Crisis One Molecule at a Time. #podcast #industryinsights

This month we kicked off our latest partnership with Formulated Solutions, a leading CDMO specializing in the development and manufacturing of innovative, high-value aerosol, topical, nasal spray, liquid oral dose, and liquid/semisolid products for the over-the-counter and regulated Rx markets. With the goal of migrating from paper to digital batch records, Formulated Solutions is deploying Apprentice at their Largo, FL headquarters and Cleveland, TN sites. The independent teams plan to leverage Apprentice’s capabilities such as parameter groups, templates, and integrations in order to streamline their records and harmonize data across the organization. We look forward to helping Formulated Solutions continue their mission to transform commercially successful products.

This month we kicked off our latest partnership with Formulated Solutions, a leading CDMO specializing in the development and manufacturing of innovative, high-value aerosol, topical, nasal spray, liquid oral dose, and liquid/semisolid products for the over-the-counter and regulated Rx markets. With the goal of migrating from paper to digital batch records, Formulated Solutions is deploying Apprentice at their Largo, FL headquarters and Cleveland, TN sites. The independent teams plan to leverage Apprentice’s capabilities such as parameter groups, templates, and integrations in order to streamline their records and harmonize data across the organization. We look forward to helping Formulated Solutions continue their mission to transform commercially successful products.

🧬 NEW EPISODE ALERT: BioIndustrial Enzymes - Nature's Tiny Factories Revolutionizing Manufacturing! We're thrilled to share the latest Apprentice.io's Industry Insights podcast! Episode 42 explores the fascinating world of industrial enzymes, where microscopic molecular machines are quietly transforming everything from your morning breakfast, to laundry, to sustainable plastics. Join us as we uncover how these biological catalysts are replacing harsh chemicals and creating tremendous value to make manufacturing and chemical processes more sustainable. Episode Highlights: · The Viking Enzyme Empire: Discover how Denmark, controls around 48% of the global enzyme market through companies like Novozymes (now Novonesis) - turning tiny microbes into industrial powerhouses worth billions · From Hot Springs to Clean Clothes: Learn how enzymes discovered in Yellowstone's boiling pools now power your laundry detergents stain-busting power, saving 80% on energy costs while cleaning better than harsh chemicals · The Bioreactor Ballet: Explore massive stainless steel bioreactors where microorganisms produce enzymes in conditions monitored with extreme precision  · Plastic-Eating Enzymes: See how Carbios developed enzymes that break down PET plastic in hours instead of centuries, promising infinite recyclability for every plastic bottle · AI-Designed Evolution: Understand how companies like Ginkgo Bioworks compress millions of years of evolution into weekend computer sessions, creating enzymes nature never imagined · The Manufacturing Challenge: When scaling from lab flask to industrial fermenter, cloud-based Manufacturing Execution Systems act as "digital catalysts" to provide the keys to success · Green Revolution Numbers: Discover how Levi's saves water in jean finishing processes, how enzymes enable carbon-negative manufacturing, and why venture capital is pouring $7.8 billion into industrial biotech This isn't just about replacing chemicals - it's about fundamentally reimagining how we make everything. Episode 42 reveals how industrial enzymes are enabling products that were literally impossible a decade ago, from self-healing concrete to infinitely recyclable plastics. Listen now to understand why enzymes represent manufacturing's sustainable future and how cloud-based MES platforms are the critical infrastructure making this biological revolution possible at scale! 🎧 Be sure to Like and Subscribe to the channel - https://lnkd.in/e3jc3Gfi #IndustrialEnzymes  #GreenManufacturing  #SustainableManufacturing  #CircularEconomy  #Novozymes  #CloudMES  #IndustryInsights  #ApprenticeIO 

Ramblr.ai® and Apprentice.io partner up to accelerate #AI in the pharmaceutical industry. Document key moments in procedures with #AIAssistants, locate and verify critical process steps and deviations from standard protocols during auditing and quality control, and extract expert knowledge from video data to support operators. Ramblr.ai®'s vision for the future of #wearable #AI is designed for leading companies to accelerate their AI solutions with real-world context. Exciting times ahead! Thanks Angelo Stracquatanio III, Frank Maggiore and the entire Apprentice.io team for the great collaboration thus far. #Wearable #AI #PharmaceuticalIndustry #Data #ContextualAI #AR #VR #LLMs #WearableComputing #PhysicalAI https://lnkd.in/eamApPeP

I am thrilled to share that the ISPE GAMP® Artificial Intelligence Guidance Document has officially been published! This long-awaited guide represents a major step forward in helping the life sciences industry navigate the practical, responsible, and compliant adoption of AI technologies within GxP environments. A heartfelt thank you to Brandi Stockton and Martin Heitmann for their incredible leadership and stewardship throughout this initiative. Your vision, clarity, and (most importantly!) patience made it possible for contributors like myself to participate—even amidst packed calendars and competing priorities. Your encouragement and flexibility meant a lot. About the Guide: A major milestone for industry has been reached! ISPE has just published the ISPE GAMP® Artificial Intelligence Guide! This Guide aims to support life science organizations in the adoption of AI in regulated areas, providing a comprehensive and holistic best practice framework. The work on this Guide was sponsored and supported by the ISPE GAMP® Community of Practice (CoP) Software Automation and Artificial Intelligence SA & AI Special Interest Group (SIG). About the Team: A global task team made the AI Guide possible under the leadership of Brandi Stockton, Eric Staib, and Martin Heitmann: Rolf Blumenthal, Taylor Chartier, Aude Chetwynd, Joanne Donald, FRQA, Stephen Ferrell, Gail Francis, Carsten Jasper, Stuart Jones, Ian Lucas, Stefan Münch, Meher Muttanapalli, Peyton Myers, Raj Nandhan R M, Tatum O'Kennedy, Mohammed Arif Rahman, Rick Rambo, Laila Rasmy, Doug Shaw, Tomos Williams, Kathy Zielinski CSPO®, CSM®, and Myself I am proud to be one of the 24 members of the task team who created the Guide - it has been an insightful journey full of learnings and new connections. I also want to thank my current company, Apprentice.io, for supporting my involvement in this important initiative. I’m deeply grateful to be part of a team that not only embraces innovation but actively supports thought leadership and industry contribution. Being given the space to serve as a core author on this guidance was a privilege I don’t take lightly. This Guide is one of the great examples of what volunteering ISPE can facilitate: Connections growing to a network, sparking ideas that are turned into reality. #ISPE #GAMP #LifeSciences #GxP #AI

Field Service Has a New Teammate. And It Doesn’t Need Coffee Breaks. After exploring Agentic AI’s role in pharma with Apprentice.io, Link:-https://lnkd.in/dHBDJDQE I turned my lens to a very different frontline -field service. What did I find? While most vendors are still debuting chatbots and dashboards, Salesforce is running a different play: one rooted in goal-driven agents, real-time orchestration, and context-aware decision-making. These aren’t just tools that respond to prompts -they pursue outcomes, reason across applications, escalate when needed, and even collaborate with humans mid-flow. > What sets this apart: A layered architecture where trust isn’t an afterthought, it's embedded Native coordination across Salesforce platforms + third-party systems. Agent-human teaming that augments, not replaces, technicians and dispatchers. This isn’t AI assisting people. It’s people and agents solving together. - I’ve unpacked it all in my new piece: “Agentic AI in the Field: How Salesforce is Orchestrating the Next Phase of FSM Autonomy.” Katelyn Burrill Sebastian Rowell Rachel Sherman Caitlin DeRango #AgenticAI #FSM #Salesforce #FieldService #FutureOfWork #AIinIndustry #DispatchAutomation #EnterpriseAI

🔬 NEW EPISODE ALERT: GLP-1 Anti-Obesity Medications - The $16.5B Manufacturing War Between Pharmaceutical Giants! We're excited to share the latest Apprentice.io's Industry Insights podcast! Episode 40 dives into the explosive world of GLP-1 medications, where breakthrough science meets billion-dollar manufacturing strategies. Join us as we unpack how Novo Holdings' $16.5 billion Catalent acquisition is reshaping the competitive landscape in the $71 billion GLP-1 market! Episode Highlights: 🏭 The Catalent Game-Changer: Discover how Novo Holdings' acquisition of Catalent's three fill-finish sites in Italy, the U.S., and Belgium gives Novo Nordisk immediate manufacturing capacity advantages over Eli Lilly - securing critical injection pen production capabilities that were previously causing supply shortages ⚡ Manufacturing Chess Match: Learn why this isn't just about current capacity - Catalent brings global small-molecule manufacturing expertise that positions Novo perfectly for the next wave of oral GLP-1 drugs, while Eli Lilly builds massive greenfield facilities that may eventually deliver lower costs but won't be ready for years 💊 The Injection vs. Oral Revolution: Understand how Novo's strategy focuses on dominating today's injectable market (Ozempic, Wegovy) through proven fill-finish capabilities, while simultaneously preparing for tomorrow's oral formulations that require completely different manufacturing approaches 🎯 Strategic Manufacturing Warfare: Explore how Eli Lilly is betting on mega-facilities and internal capacity building, while Novo chose the "buy vs. build" approach to secure immediate market share - a classic pharmaceutical industry strategy battle worth billions 📊 The $100B Market Stakes: See how manufacturing capacity directly translates to market dominance when demand for GLP-1s is exploding - every injection pen filled is revenue captured, and Catalent's expertise means Novo can scale faster than competitors 🔬 Beyond Fill-Finish: Discover how Catalent's small-molecule capabilities position Novo for the next generation of oral GLP-1s, dual-pathway drugs, and combination therapies that will define the future of obesity treatment This isn't just about manufacturing capacity - it's about securing the infrastructure to dominate one of the fastest-growing pharmaceutical markets in history. Episode 40 reveals how the convergence of breakthrough science and strategic manufacturing investments is creating winners and losers in the race to solve humanity's obesity crisis. Listen now to understand why manufacturing strategy is becoming the ultimate competitive advantage in the GLP-1 revolution and how billion-dollar acquisitions are reshaping the pharmaceutical landscape! 🎧 Be sure to Like and Subscribe to the channel - https://lnkd.in/etSSNuT7 #GLP1  #Semaglutide  #Tirzepatide  #AntiObesity  #PharmaManufacturing  #CloudMES  #BiologicsManufacturing  #IndustryInsights  #ApprenticeIO 

Wow — standing room only, powerful conversations, and a community ready to build what’s next. Our relaunch event explored the collision of art, tech, and community in Jersey City — plus a fiery AI debate that had everyone leaning in. 📖 Read the full recap: https://lnkd.in/erPbTV7R Ben Yurcisin Amari Williams Janet Alicea Angelo Stracquatanio III Kristen Kucks Apprentice.io TechWalk

Is compliance still a paper trail game? Or is it quietly becoming an AI-driven ecosystem that checks itself - in real time? Been exploring how companies like Apprentice.io are using agentic AI not just to automate steps, but to embed quality, traceability, and continuous improvement directly into the fabric of manufacturing. >>Imagine a network of AI agents that don’t just execute tasks, but cross-verify, escalate, and learn - so by the time data moves downstream, it’s already passed multiple layers of digital peer review. Compliance isn’t a bottleneck anymore; it’s a built-in, ever-improving safeguard. Feels like we’re on the edge of something big here. Curious: Is this the future of regulated industries? How soon before compliance isn’t an “after the fact” audit, but a live, evolving AI fabric? Would love to hear how others see this playing out. Kristen Kucks Emilee Cook Donovan Price Christopher Beaupre Narayan Gokhale Akaash Ravikumar IGNATIUS DANIEL T Sujan Thomas Mathew